A reliable and early diagnosis of viral infections and rejection episodes is a major goal of immunologic monitoring in transplantation . Soluble markers like the cytokines, neopterin or serum amyloid A are frequently recommended as diagnostic parameters. However they are not often used routinely in transplant medicine.
A reliable and early diagnosis of viral infections and rejection episodes is a major goal of immunologic monitoring in transplantation . Soluble markers like the cytokines, neopterin or serum amyloid A are frequently recommended as diagnostic parameters. However they are not often used routinely in transplant medicine.
The study investigates the diagnostic value of plasma (P), serum (S), and urine (U) levels of neopterin (S-/U-NEOP), serum amyloid A (SAA), tumor necrosis factor-a, ( P-/U -TNF-a), soluble interleukin-2 receptor (P-/U -sIL-2R), and interleukin-6 (U -IL-6) in transplant monitoring and describes an approach for their use in the clinical routine decision making.
In 29 renal transplant patients blood and urine samples were collected daily during the posttransplant course on ward. The cytokines were measured by ELISAs, neopterin b y RIA, and SAA by immunonephelometry. Descriptive statistics, sensitivity and specificity, day of first significant parameter increase/decrease, receiver operating characteristic curves, and post-test probabilities were calculated for each parameter.
12 acute rejection episodes were diagnosed. As rejection markers, S-NEOP and P-TNF-a had the highest sensitivity, U-IL-6 the highest specificity. 8 viral infections occurred. U-NEOP showed values higher than 1000 /-lmol!moICrea. It did not exceed this threshold in case of rejection episodes. SAA and U-IL-6 showed peak. levels during rejections but not during episodes of viral infections. Using the calculated likelihood ratio formulas the probability for the occurrence of an acute rejection could be estimated for the individual, daily parameter measurement. Adding the physician IS rating for rejection posttest probabilities were computed.
Immunologic monitoring is possible in transplant medicine. Using daily measurements of serum amyloid A and neopterin facilitates the differential diagnosis of acute rejection episodes and viral infections. The likelihood ratio approach permits an application of the parameter monitoring in the clinical routine.
Introduction
Rejection episodes and viral infections are the main complications in the early postoperative course following organ transplantation . A reliable and early differential diagnosis of these events remains to be a major goal of noninvasive immunological monitoring in transplant medicine ( 1) .
Soluble mediators regulate the immune response (2-4). The cytokines interleukin 1, interleukin 6, and tumor necrosis factor alpha induce the synthesis of acute phase proteins like serum amyloid A (5,6). Neopterin, a pteridine d erivative, is released by human macrophages upon stimulation by interferon gamma (7,8). New assays for the quantitation of these mediators offer the possibility of a noninvasive monitoring (9-13).
In the underlying study the parameters neopterin, serum amyloid A, tumor necrosis factor alpha, soluble interleukin 2 receptor, and interleukin 6 were measured daily and their diagnostic value was investigated.
Materials and Methods

Patients and immunosuppression
Twenty-nine consecutive patients (9 female, 20 male) received a cadaveric kidney transplant between July 1989 and August 1990 at the PhilippsUniversity of Marburg. Their mean age was 47 .3 years (range 23 to 67 years). The mean period of observation on the ward was 32.9 days (range 4 to 109 days).
All patients received postoperatively a basic immunosuppressive therapy with cyclosporine (CsA; Sandoz®, Basel, Switzerland) and prednisolone (PRED; Hoechst AG®, Frankfurt, Germany). Prednisolone started with 80 mg on day 1 and was tapered to 20 mg on day 4 after transplantation. Cyclosporine was started intravenously with 5 mg/ kg body weight on day 1, continued orally at 10 mg/ kg body weight and was adapted to blood trough levels of 200 to 250 ng per ml.
Acute rejection episodes were treated by steroid pulse therapy over 3 days, starting with 0.5 g methyl-prednisolone (Urbason; Hoechst AG®, Frankfurt, Germany) per day. In case of steroid-resistance a core needle biopsy was performed with the subsequent administration of the monoclonal antibody OKT3 (Cilag®, Sulzbach, Germany) .
In patients with delayed graft function due to acute tubular necrosis the polyclonal antibod\-preparation ATG (Fresenius®, Bad Homburg, GerPteridines/ Vol. 9 / No. 2 Neumann et al.: Monitoring after renal transplantation many) was used as induction therapy replacing cyclosporine on the first postoperative day. After onset of graft function cyclosporine was reinstituted with a 3-day overlap with ATG.
The dosage of both the polyclonal antibody ATG as well as the monoclonal antibody OKT3 was adjusted to T cell numbers (target level of S; 50 cells/ !J.I) .
Cytomegalovirus (CMV) antibody enriched hyperimmunoglobulin (Cytotect; Biotest®, Dreieich, Germany or Cytoglobin; Bayer®, Leverkusen, Germany) was given (twice weekly during the first three postoperative weeks) in case of positive CMV donor serostatus and/or negative CMV recipient serostatus as well as during administration of mono-or polyclonal antibodies.
Clinical events
Rejection episodes: Acute rejection episodes were diagnosed by a declining creatinine clearance when other non-immunological causes of graft failure were ruled out. In addition, a positive response to the immunosuppressive antirejection therapy was mandatory. Facultatively and in case of steroidresistance, fine needle as well as core needle biopsies were performed to support the clinical diagnosis. To allow comparisons between patients, the first day of clinically diagnosed rejection (i.e. start of antirejection therapy) was labelled as day O. Subsequently, the days before and after day 0 were labelled, starting with day -3 (i.e . three days before day 0) and ending with day +2 ( i.e . two days after day 0) .
Stable graft function : Periods of stable graft function were defined as time intervals of at least 6 days duration where complications such as rejection episodes, viral infections, acute tubular necrosis, surgical interventions, and therapies with mono-or polyclonal antibodies were ruled out by clincal and laboratory findings . The first 3 postoperative days were never considered for evaluation.
Viral infections: The diagnosis of viral infections was based on positive laboratory findings as detection of viral antigens, positive viral cultures, and conversion or 4-fold increases in the IgG or IgM viral antibody titers. The first day of a positive laboratory test was defined as the beginning of the viral infection, and vice versa, the first negative result as the end of the infectious process.
Parameters Neopterin (NEOP): Serum (S) and urine (U)
neopterin (S-/U-NEOP) levels were measured by radioimmunoassay (RIAcid; Henning/Brahms Diagnostica®, Berlin, Germany) . U-NEOP was related to creatinine excretion and expressed as J..lmol/ mol creatinine. S-NEOP was measured in nmol/1. Serum Amyloid A (SAA) : A rapid immunonephelometric assay was developed to measure SAA levels. The method is described in Hocke et al. (14) . Basically specific antibodies were raised against purified SAA in sheep. The antigen-antibody complexes were measured by a laser nephelometer (Behringwerke AG®, Marburg, Germany). The concentrations are expressed as mg/ 100 ml, with a lower level of detection of 1.5 mg/IOO mi.
Cytokines (TNF-a, IL-6, sIL-2R): The cytokines were measured by commercial sandwich enzyme immunoassays in plasma (P) and urine (U). The samples were collected daily during the stay on ward.
Blood was drawn into EDTA tubes (Sarstedt
containing 0.25 ml aprotinin (Trasylol; Bayer' :ro , 20000 KIE/ml). The samples were immediately cooled and centrifuged at 3000 g for 10 mins at 4°C. Supernatants were separated into 300 J..lI fractions, frozen immediately and stored at -70°C. Daily samples of spontaneously voided morning urine (between 6 and 7 a.m.) were put into sterile containers (Sarstedt®) and again immediately cooled. These were separated into 300 J..ll fractions, frozen immediately and stored at -70"C . In cases of pyuria or hematuria they were centrifuged beforehand.
Tumor necrosis factor alpha (TNF-a; Endogen Inc.®, Boston, MA, USA) and soluble interleukin 6 receptor (sIL-2R; T Cell Diagnostics®, Cambridge, MA, USA) were determined in plasma and urine (P-/U-TNF-a and P-/ U-s-IL-2R). Interleukin 6 (IL-6; Endogen Inc.@, Boston, MA, USA) was measured in urine samples only (U-IL-6).
Analysis of the data
AlI parameters investigated were measured daily. The values were entered together with the clinical observations into a data base and displayed graphically for retrospective analysis. The statistical analysis was performed using the SAS statistical computer program package (SAS Institute(, Cary, NC, USA).
Defining clinical events: The postoperative courses were analysed retrospectively and 6-day periods of interest were defined (day -3 to day +2) for rejection episodes and stable graft function .
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Each rejection episode was matched with a corresponding 6-day period of stable graft function of another patient . For each pair, the time of occurrence in the postoperative course as well as the number of HLA mismatches was matched . In addition periods of viral infections and delayed graft function were defined.
Cumulative p'!:.rameter analysis: The mean parameter values (x, ±standard deviation SD) were calculated for each of the different clinical events and compared using Wilcoxon and Brown-Mood tests . In addition the mean parameter values obtained for each day during the time course of all rejection episodes were compared with those calculated for the periods of viral infections .
Individual parameter analysis: Following the cumulative analysis of the values the individual dayto-day parameter behaviour was analysed during the periods of rejection and stable graft function using the Bayesian concept. A logistic regression analysis was performed to calculate the optimum cut-off value for each parameter to differentiate between rejection and stable graft function. Both, the absolute parameter values and the relative changes in the day-to-day course were analysed. Receiver operating curves (ROC) were computed. Sensitivity, specificity, and the day of the first true positive increase in regard to the diagnosed rejection episodes were calculated and displayed for the different parameters.
Using the data obtained by logistic regression analysis likelihood ratios for the probability of rejection were estimated for particular levels of the individual parameters . In addition post-test probabilities for rejection were calculated in regard to different levels of physician's pre-test rating.
Results
Alltogether in the 29 renal allograft reCIpIents 12 acute reversible rejection episodes, 16 periods of delayed graft function, and 8 viral infections (2 cytomegalovirus and 6 herpes simplex virus infections) occurred . Figure 1 gives an example of a prolonged but reversible acute renal allograft rejection episode . The antirejection therapy was started on postoperative day 7. The cytokines U-IL-6, P-/ U-TNF-a, and P-/ U-sIL-2R begin to rise 3 to 4 days before the clinical diagnosis was made. They are followed by SAA and S-NEOP increases. The 
Example of an acute rejection episode
81 - U-NEOP levels do not show a significant increase. The rejection episode is successfully treated with a second steroid bolus therapy as shown by the increase in urine volume, decrease in serum creatinine values and faJ.I of the immune markers . The extent of the interindividual differences in the mean parameter levels in the different groups of clinical complications is demonstrated in Figure  2 . Here the distribution in the mean P-TNF-a and S-NEOP levels calculated for each individual event is shown.
Comparison of the parameter values m easured during acute rejections with those during stable graft function
Time course of the m ean parameter values during periods of viral infection and rejection episodes
In Figure 3 the longitudinal courses of the mean parameter values during 12 rejection episodes are compared with those during 8 periods of viral infections.
U-TNF-a shows increasing values during both clinical events. SAA rises at the day of rejection diagnosis. U-NEOP shows a steep increase with peak values above 1 000 ~moljmol crea during the periods of viral infection. It does not exceed this threshold during the 12 rejection episodes . In contrast U-IL-6 increases only in patients developing rejection episodes and remains under the lower limit of detection during the viral infections. 
Diagnostic value of the paramete rs during rejection episodes and stable graft function
Receiver operating characteristic (ROC) curves for the different parameters are shown in Figure 4 . They describe the relationship between sensitivity and specificity of the markers at different cut-off' levels . P-TNF-a and U-IL-6 reached at their optimum cut-off level the highest sensitivity and specificity, respectively.
The diagnostic qualities sensitivity and specificity of the parameters in respect to the timepoint of the clinical diagnosis of rejection are shown in Figure 5 . P-and U -IL-2R were the earliest predictors of an impending allograft rejection, increasing significantly in the mean 2.2 and 2.1 days before the antirejection therapy was started. 117 Both, the NEOP and SAA levels responded later than the cytokines during the rejection process. P-TNF-a and S-NEOP were the markers with the highest sensitivity, U-IL-6 and SAA those with the highest specificity, respectively.
Estimation of post-test probabilities for rejection
In Table 2 likelihood ratio functions, obtained from the data base by logistic regression, are given for the different parameters . These formulas allow the estimation of the probability for the occurrence of an acute rejection associated with an individual parameter measurement.
Together with the physician's rating of the patient's probability for rejection (i.e. the pre-test probability) these formulas can be used to calculate the post-test probability. Figure 6 shows post-test probabilities for a rejection according to two different levels of pre-test probability (10% versus 90%) for particular parameter values. It is evident that the physician's rating influences the probability of a rejection for a given parameter n1easurement.
Discussion
The cytokine network plays the key role in the initiation and regulation of the immune response and recruitment of inflammatolY systems in alloreactivity (2, 15) . The underlying study evaluates the cytokines TNF-a, sIL-2R, and IL-6 together with the mediators NEOP and SAA as diagnostic parameters for a noninvasive immunologic monitoring in the postoperative course after renal transplantation .
The analysis comparing median or mean parameter values between groups of various clinical events showed trends in the differential parameter behaviour. In the rejection group the median values for P-TNF-a, U-TNF-a, and U-IL-6 were significantly higher than in the group with stable graft function (Table 1 ) . Comparing mean parameter values in the time course of the rejections versus the "iral infections marked increases of SAA and U -IL-6 occurred in the rejection group. In contrast the viral infections were associated with a strong increase in the U-NEOP levels, exceeding 1000 )lmol per mol creatinine (Fig. 3) .
This pattern reflects differences in the immune response against viral and allograft antigens. The site-restricted immune response against the alloantigens of the graft is primarily MHC class II acute rejection episodes (n=12) :Et,mOJ. . an acute phase response detectable by increases in SAA or C-reactive protein (2, 13 ,16,17) . The immune response against viruses is primarily MHC class I dependent and involves cytotoxic CD8 positive T cells, NK natural killer cells, and macrophages. The key cytokine in the antiviral Immune response is interferon gamma, which 10-duces neopterin release (7,12 ,18 ) . However evaluating the diagnostic performance of the parameters using mean and median values is of limited value. The parameter: .. levels are characterized by high interindividual difterences (Fig. 2) . In addition the intraindividual changes in serial measurements are neglected by a cumulative analysis. Despite these limitations cumulative analyses are still common practice in studies on the d iagnostic value of immunologic parameters ( 10, 16, 19 ) .
In an individualized approach using a logistic regression analysis the day-to-day changes in the parameter values were analysed according to sensitivity, specificity, and day of first positive increase in regard to the diagnosis of rejection (Fig.  S) . In addition the ROC curves were plotted (Fig.  4) . As a rejection marker P-TNF-a showed the highest sensitivity and U -IL-6 the highest specificity . As a rule, the cytokine increase preceeded the SAA and NEOP peaks. The findings in the kinetics of the Immune markers are supported by other studies. The cyto kine release induces and regulates the mcrease in parameters like SAA and NEap (20, 21) .
Concerning the diagnostic accuracy of the parameters comparisons with other studies are dif~ ficult due to differences in the test assays, clinical criteria, goldstandards, and -most of all -intervals and frequencies of measurements. McLaughlin calculated a sensitivity of 65% and a specificity of 87% for S-TNF~a ( 11). Maury used the radial immunodiffUsion method for SAA determinations. Comparable to the underlying results SAA showed a positive predictive value of 82% (22) . Schaefer calculated a sensitivity of 86% for S-NEOP values, slightly lower than in the underlying study (23) . In an analysis of 5 different parameters Ma~ galini described a high number of false negative results for s~IL-2R in plasma. The diagnostic quality of sIL-2R was inferior to that of SAA and SNEap (24 ) . In regard to studies concerning the diagnostic quality of cyrokines tor transplant monitoring about 60 articles are known to the authors. Less than one fourth of these studies provided de~ tailed information on the test criteria used. Only one study used ROC curves to characterise the parameters (10).
The analyses of diagnostic sensitivity and specificity, calculation of ROC curves, and determination of the time-points of parameter changes are helpful in the characterisation of the parameter behaviours in different clinical settings and allow comparisons between the different markers. However these analyses are not readily applicable for the daily clinical routine . In particular the particular parameter measurement is not easily transformed into an explicite clinical deClSlon. The dichotomous diagnostic tests used reduce the quantitative information into a qualitative binary result, i.e. normal/abnormal, above/ below a cut-off level (8, 25, 26) .
Therefore likelihood ratio formulas for the occurrence of rejections in regard to particular paralnter measurements were estimated using logistic regression analysis (Table 2 ). In order to include the physician 's clinical impression of the likelihood for a rejection a calculation of the posttest probability based on the individual parameter Table 2 . Likelihood ratio fimctions for the rejection markers. The logarithmic likelihood ratio (LLR ) iormulas to estimate the probability of an acute rejection episode associated with a particular paramete r measurement are given 
